BAROZZI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 21.106
EU - Europa 8.996
AS - Asia 8.107
SA - Sud America 1.035
Continente sconosciuto - Info sul continente non disponibili 312
AF - Africa 187
OC - Oceania 9
Totale 39.752
Nazione #
US - Stati Uniti d'America 20.757
GB - Regno Unito 3.105
CN - Cina 2.262
SG - Singapore 2.261
IT - Italia 1.914
HK - Hong Kong 1.083
SE - Svezia 913
VN - Vietnam 824
BR - Brasile 774
DE - Germania 676
FI - Finlandia 587
UA - Ucraina 400
RU - Federazione Russa 396
FR - Francia 361
BD - Bangladesh 349
TR - Turchia 329
KR - Corea 224
IN - India 219
CA - Canada 169
BG - Bulgaria 153
NL - Olanda 105
ID - Indonesia 95
AR - Argentina 85
MX - Messico 80
JP - Giappone 65
IQ - Iraq 57
BE - Belgio 49
ZA - Sudafrica 48
PL - Polonia 45
ES - Italia 44
AE - Emirati Arabi Uniti 42
CO - Colombia 40
CZ - Repubblica Ceca 40
EC - Ecuador 40
IE - Irlanda 39
IR - Iran 38
CL - Cile 31
PK - Pakistan 31
PH - Filippine 30
AT - Austria 29
LT - Lituania 29
BZ - Belize 26
MA - Marocco 24
VE - Venezuela 24
MY - Malesia 22
AZ - Azerbaigian 21
KE - Kenya 21
UZ - Uzbekistan 21
EG - Egitto 18
JM - Giamaica 18
RO - Romania 18
PY - Paraguay 17
TN - Tunisia 17
DZ - Algeria 16
EU - Europa 16
SA - Arabia Saudita 16
CR - Costa Rica 15
JO - Giordania 14
NP - Nepal 12
CY - Cipro 11
CH - Svizzera 9
DK - Danimarca 9
ET - Etiopia 9
IL - Israele 9
PT - Portogallo 9
SK - Slovacchia (Repubblica Slovacca) 9
TH - Thailandia 9
TW - Taiwan 9
UY - Uruguay 9
AL - Albania 8
AU - Australia 8
PE - Perù 8
NI - Nicaragua 7
PS - Palestinian Territory 7
RS - Serbia 7
BO - Bolivia 6
GR - Grecia 6
KZ - Kazakistan 6
QA - Qatar 6
DO - Repubblica Dominicana 5
EE - Estonia 5
KG - Kirghizistan 5
MD - Moldavia 5
NG - Nigeria 5
OM - Oman 5
PA - Panama 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
GT - Guatemala 4
LB - Libano 4
LV - Lettonia 4
PR - Porto Rico 4
SI - Slovenia 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
HN - Honduras 3
HU - Ungheria 3
Totale 39.402
Città #
Southend 2.310
Ashburn 2.039
Fairfield 1.978
Santa Clara 1.638
Singapore 1.441
Woodbridge 1.279
Hong Kong 1.070
Houston 960
Chandler 956
Ann Arbor 820
Jacksonville 785
Hefei 771
Seattle 739
San Jose 720
Wilmington 697
Dearborn 655
Cambridge 590
Nyköping 504
Council Bluffs 462
Helsinki 417
Los Angeles 392
Beijing 385
London 381
Chicago 370
New York 326
Modena 297
Ho Chi Minh City 275
The Dalles 267
Seoul 205
Milan 199
Izmir 190
Hanoi 178
Buffalo 177
San Diego 165
Princeton 149
Sofia 149
Eugene 139
Salt Lake City 128
Dallas 123
Lauterbourg 119
Moscow 107
Munich 107
Columbus 92
Rome 90
Fremont 89
Shanghai 77
São Paulo 74
Bremen 71
Des Moines 70
Bologna 67
Tampa 64
Boardman 63
Elk Grove Village 57
Orem 56
Jakarta 54
Tokyo 53
Atlanta 51
Frankfurt am Main 51
Redwood City 48
Phoenix 43
Da Nang 42
Montreal 42
Philadelphia 42
Brussels 40
Brooklyn 39
Haiphong 39
Dublin 37
Toronto 36
Chennai 34
Albuquerque 33
Boston 32
Turku 31
Lancaster 30
Naples 30
Denver 29
Las Vegas 29
Miami 29
Kent 28
North Bergen 28
Johannesburg 27
Paris 27
Warsaw 27
Belize City 26
Ottawa 26
Miano 25
Rio de Janeiro 25
Reggio Emilia 24
Stockholm 24
Guangzhou 23
Mexico City 23
Nanjing 23
Norwalk 23
Verona 23
Washington 23
Baghdad 22
Amsterdam 21
Leawood 21
San Francisco 21
Sterling 21
Detroit 20
Totale 27.974
Nome #
HHV-6A in syncytial giant-cell hepatitis 476
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 457
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 448
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 446
B cells and herpesviruses: a model of lymphoproliferation 435
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 426
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 414
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 414
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 380
Mucorales-specific T cells in patients with hematologic malignancies 380
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 377
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 377
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 372
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 369
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 369
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 365
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 364
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 364
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 364
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 363
Acute appendicitis in adult neutropenic patients with hematologic malignancies 360
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 357
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 356
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 353
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 352
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 352
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 351
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 350
Translational challenges of human herpesvirus 6 chromosomal integration. 349
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 345
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 331
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 330
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 329
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 329
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 327
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 323
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 323
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 323
Parvoviruses in blood donors and transplant patients, Italy 318
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 317
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 316
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 315
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 312
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 310
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 307
Diagnosis of aspergillosis: Role of proteomics 307
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 301
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 298
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 296
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 294
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 292
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 292
HHV-8 infection in the transplantation setting: A concern only for solid organ transplant patients? 290
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 289
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 286
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 286
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 285
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 285
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 284
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 284
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 282
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 280
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 277
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 275
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 271
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 271
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 268
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 267
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 265
Late-appearing PML/RAR alpha fusion transcript with coincidental t(12;13)(p13.2;q14) in acute promyelocytic leukemia lacking the t(15;17) cytogenetic anomaly 264
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 262
How I treat HHV8/KSHV-related diseases in posttransplant patients. 262
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 260
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 258
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 254
Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies 253
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 252
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 250
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 250
Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients 249
HUMAN HERPESVIRUS-6 - A SURVEY OF PRESENCE AND DISTRIBUTION OF GENOMIC SEQUENCES IN NORMAL BRAIN AND NEUROGLIAL TUMORS 249
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 248
Human herpesvirus-8 infection in hemodialysis patients from northern Italy. 248
Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission 245
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 243
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 243
Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia 241
Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation 238
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 233
Human herpesvirus-6 (HHV-6) in blood donors 231
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 229
Polymerase chain reaction detection of human herpesvirus 8 sequences in primary central nervous system lymphomas 228
Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease 227
Human herpesvirus-6 reactivation in a longitudinal study of two HIV-1 infected patients 226
CHARACTERIZATION OF HUMAN HERPESVIRUS-6 GENOMES FROM CASES OF LATENT INFECTION IN HUMAN LYMPHOMAS AND IMMUNE DISORDERS 225
Human herpesvirus 6 infection in normal human brain tissue 225
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 224
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 220
Hepatitis C virus-induced leuko-thrombocytopenia and haemolysis 215
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 214
Totale 30.586
Categoria #
all - tutte 152.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.303 0 0 381 171 57 98 181 136 264 189 505 321
2022/20232.915 391 322 173 284 429 388 75 277 298 36 148 94
2023/20241.938 66 110 137 167 410 206 218 284 35 38 85 182
2024/20255.820 248 71 101 426 1.053 832 454 324 609 240 617 845
2025/202611.428 814 507 1.072 1.219 1.812 877 1.346 564 1.110 949 716 442
2026/20271.076 340 690 46 0 0 0 0 0 0 0 0 0
Totale 39.752